Among COVID-19+ participants, higher BMI was associated with a striking amplification of the SARS-CoV-2 humoral repertoire, with significantly higher IgG, IgA, and IgM levels and almost all antibody-specific FcγRIIA binding abilities (Figure 7, B and D). This evidence concerns the gene CD79A and COVID-19.